FMS — FRESENIUS MEDICAL CARE CORPORATION (Healthcare >> Medical Care Facilities)
FMS FAQ
What is FMS's P/E ratio?
FRESENIUS MEDICAL CARE CORPORATION (FMS) currently trades at a P/E ratio of 12.52.
What is FMS's ROE?
FRESENIUS MEDICAL CARE CORPORATION reports a Return on Equity (ROE) of 7.13%.
What is FMS's dividend yield?
FRESENIUS MEDICAL CARE CORPORATION offers a dividend yield of 3.97%.
What is FMS's Deepscope Quality Score?
Deepscope rates FMS's overall financial quality at 62 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy FMS?
Deepscope's AI Timing Score for FMS is 27 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does FMS belong to?
FRESENIUS MEDICAL CARE CORPORATION is classified under the Healthcare >> Medical Care Facilities sector on the NYSE exchange.
|
USD 22.03
Price
0.10
(0.46%)
Day Change
|
|
|---|
FMS มีคุณภาพโดยรวมพอใช้ ( คะแนนปัจจัยพื้นฐาน = 62) และ จังหวะเข้าซื้อ ...(ล็อกอินเพื่อดู)...
- Signal
- NEUTRAL
- Signal Description
- Company financial health is OK
- Reason
-
อัตราผลตอบแทนผู้ถือหุ้น (ROE) ค่อนข้างต่ำ
อัตราผลตอบแทนผู้ถือหุ้น (ROE) ในอดีต ค่อนข้างต่ำ
อัตราผลตอบแทนสินทรัพย์ (ROA) ค่อนข้างต่ำเมื่อเทียบกับอัตราผลตอบแทนผู้ถือหุ้น(ROE)
อัตรากำไรสุทธิ ค่อนข้างต่ำ
อัตรากำไรสุทธิในอดีต ค่อนข้างต่ำ
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
ถ้าดูอย่างละเอียดจะพบว่า ปัจจัยทางคุณภาพ ยังไม่ดีนัก สุขภาพทางการเงิน ยังไม่ดีนัก และ ประสิทธิภาพการทำกำไร ยังไม่ดีนัก , ...
| ปัจจัยทางคุณภาพ |
|
57% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 99 |
| Magic Formula Rank by ROA |
1391
|
| Magic Formula Rank by ROE |
1391
|
| Magic Formula Rank by ROIC |
1315
|
| Price | 22.03 |
| PBV / Sector |
0.83 / 327.78
GREAT
|
| Earning Per Share | 1.76 |
| PE / Sector |
12.52 / 19.65
GOOD
|
| PEG or PE/Growth / Sector |
0.27 / -0.57
GREAT
|
| Average 1M Daily Value |
16.60 M
GREAT
|
| Average 1W Daily Value |
19.25 M
GREAT
|
| ปัจจัยทางเทคนิค |
|
57% |
| สุขภาพทางการเงิน |
|
50% |
| ประสิทธิภาพการทำกำไร |
|
58% |
| ผลตอบแทนต่อผู้ถือหุ้น |
|
33% |
| รายละเอียดการจดทะเบียน |
| Analyze Date | 2026-06-06 09:08:37 |
| Symbol | FMS |
| Name | FRESENIUS MEDICAL CARE CORPORATION |
| Sector | Healthcare >> Medical Care Facilities |
| Market | NYSE |
| Listed Shares | 537.13 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 11,827.59 / 6,090.85 |
| ข่าว, ประมาณการ, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: Else-Kröner-Strasse 1, Bad Homburg, Germany, 61352
Phone: 49 6172 609 0
Website: https://www.freseniusmedicalcare.com
Employees: 108,165
Description: Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company operates through Care Delivery and Care Enablement segments. It also develops, manufactures, and distributes various health care products, including hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular specialty, ambulatory surgery center, physician nephrology practice management, pharmacy and other services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics, as well as through local sales forces, independent distributors, dealers, and sales agents. The company was incorporated in 1996 and is headquartered in Bad Homburg, Germany.
ME vs SECTOR Healthcare >> Medical Care Facilities
Click a bubble to view stock details · Bubble size represents market capitalization share
Google